Company
ZEVRA THERAPEUTICS, INC.
ZVRA · CIK 0001434647
Sale of 20,000 shares at $11.2474 per share.
Reporting Person McFarlane Neil F. · Officer Title President and CEO · Transaction Code S
Traded Oct 12, 2026 · Disclosed Oct 13, 2026
Source: SEC Form 4 · 0001434647-26-000075 · filed 2026-10-13 · View filing →
Acquisition (code M) of 50,000 shares; price not stated (see filing).
Reporting Person McFarlane Neil F. · Officer Title President and CEO · Transaction Code M
Traded Oct 10, 2026 · Disclosed Oct 13, 2026
Source: SEC Form 4 · 0001434647-26-000075 · filed 2026-10-13 · View filing →
Sale of 42,666 shares at $11.1277 per share.
Reporting Person Thompson Rahsaan · Officer Title Chief Legal & Compliance · Transaction Code S
Traded Aug 14, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001434647-26-000073 · filed 2026-08-17 · View filing →
Acquisition (code M) of 12,300 shares at $4.97 per share.
Reporting Person Watton Corey Michael · Transaction Code M
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001434647-26-000070 · filed 2026-08-12 · View filing →
Sale of 12,300 shares at $11.2502 per share.
Reporting Person Watton Corey Michael · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001434647-26-000070 · filed 2026-08-12 · View filing →